eISSN: 1731-2531
ISSN: 1642-5758
Anaesthesiology Intensive Therapy
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2024
vol. 56
 
Share:
Share:
Letter to the Editor

Perioperative utilization of tranexamic acid in total knee and hip arthroplasty procedures in Poland – a survey-based study

Dorota Studzińska
1, 2
,
Izabela Pabjańczyk
1, 3
,
Kamil Polok
4
,
Wojciech Szczeklik
1, 3

  1. Centre for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Krakow, Poland
  2. Department of Vascular Surgery and Angiology, St. John Grande Hospital in Krakow, Poland
  3. Department of Intensive Care and Anaesthesiology, 5th Military Hospital with Polyclinic, Krakow, Poland
  4. Department of Pulmonology, Jagiellonian University Medical College, Krakow, Poland
Anaesthesiol Intensive Ther 2024; 56, 3: 206–207
Online publish date: 2024/08/30
Article file
Get citation
 
PlumX metrics:
 
1. Roshanov PS, Eikelboom JW, Sessler DI, Kearon C, Guyatt GH, Crowther M, et al. Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study establishing diagnostic criteria and prognostic importance. Br J Anaesth 2021; 126: 163-171. DOI: 10.1016/j.bja.2020.06.051.
2. Pavenski K, Ward SE, Hare GMT, Freedman J, Pulendrarajah R, Piraniet RA, et al. A rationale for universal tranexamic acid in major joint arthroplasty: overall efficacy and impact of risk factors for transfusion. Transfusion 2019; 59: 207-216. DOI: 10.1111/trf.14995.
3. Gandhi R, Evans HMK, Mahomed SR, Maho-med NN. Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis. BMC Res Notes 2013; 6: 184. DOI: 10.1186/1756-0500-6-184.
4. Sun Y, Jiang C, Li Q. A systematic review and meta-analysis comparing combined intravenous and topical tranexamic acid with intravenous administration alone in THA. PLoS One 2017; 12: e0186174. DOI: 10.1371/journal.pone.0186174.
5. Grzelecki D, Dudek P, Okoń T, Marczak D, Kordasiewicz B, Sibiński M, et al. Efficacy of intravenous tranexamic acid administration in revision hip arthroplasty. Orthopade 2021; 50: 464-470. DOI: 10.1007/s00132-020-03959-9.
6. Patel PA, Wyrobek JA, Butwick AJ, Pivalizza EG, Hare GMT, Mazer CD, et al. Update on applications and limitations of perioperative tranexamic acid. Anesth Analg 2022; 135: 460-473. DOI: 10.1213/ANE.0000000000006039.
7. Fillingham YA, Ramkumar DB, Jevsevar DS, et al. Tranexamic acid in total joint arthroplasty: the endorsed clinical practice guides of the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society. Reg Anesth Pain Med 2019; 44: 7-11. DOI: 10.1136/rapm-2018-000024.
8. Pabjańczyk I, Owczuk R, Kutaj-Wąsikowska H, Fronczek J, Węgrzyn K, Jasińska M, et al. Standards of perioperative management in total knee and hip arthroplasty procedures. A survey-based study. Part I: Preoperative management. Anaesthesiol Intensive Ther 2023; 55: 262-271. DOI: 10.5114/ait.2023.132832.
9. Young B, Moondi P. A questionnaire-based survey investigating the current use of tranexamic acid in traumatic haemorrhage and elective hip and knee arthroplasty. JRSM Open 2014; 5: 204253331351694. DOI: 10.1177/2042533313516949.
10. Devereaux PJ, Marcucci M, Painter TW, Conen D, Lomivorotov V, Sessler DI, et al. Tranexamic acid in patients undergoing noncardiac surgery. N Engl J Med 2022; 386: 1986-1997. DOI: 10.1056/NEJM­oa2201171.
11. Zak SG, Tang A, Sharan M, Waren D, Rozell JC, Schwarzkopf R. Tranexamic acid is safe in patients with a history of coronary artery disease undergoing total joint arthroplasty. J Bone Joint Surg Am 2021; 103: 900-904. DOI: 10.2106/JBJS.20.01226.
This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.